Creative Medical Technology Holdings, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Creative Medical Technology Holdings, Inc. (CELZ) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $1.57 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-20.
Financial Statements › Notes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-20
- Creative Medical Technology Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $1.57M, a 9.76% increase from fiscal 2024.
- Creative Medical Technology Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $1.43M, a 3.71% increase from fiscal 2023.
- Creative Medical Technology Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $1.38M, a 48.36% decline from fiscal 2022.
- Creative Medical Technology Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $2.68M, a 543.89% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $1.57M 10-K · filed 2026-03-20 | |
| 2024-12-31 | $1.43M 10-K · filed 2026-03-20 | |
| 2023-12-31 | $1.38M 10-K · filed 2025-03-14 | |
| 2022-12-31 | $2.68M 10-K · filed 2024-03-22 | |
| 2021-12-31 | $416.06K 10-K · filed 2023-03-31 | |
| 2020-12-31 | $320.44K 10-K · filed 2022-03-30 | |
| 2019-12-31 | -$348.59K 10-K · filed 2021-03-17 | |
| 2018-12-31 | $13.85K 10-K · filed 2020-04-06 | |
| 2017-12-31 | -$904.10K 10-K · filed 2019-04-01 | |
| 2016-12-31 | -$260.46K 10-K · filed 2018-03-29 | -$260.46K 10-K · filed 2017-02-13 |
| 2015-12-31 | $0.00 10-K · filed 2017-02-13 | $3.32K 10-K · filed 2016-04-14 |
| 2014-12-31 | $2.91K 10-K · filed 2015-02-27 | |
| 2013-12-31 | $3.02K 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |